Formidable Asset Management’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Formidable Asset Management’s Portfolio TTPH Stock Details TTPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-791	Closed	-$751K	–	649
2015 Q2	$751K	Buy	791 +500	+172%	+$409K	0.48%	48
2015 Q1	$237K	Buy	291 +217	+293%	+$163K	0.16%	123
2014 Q4	$59K	Buy	74 +20	+37%	+$10.8K	0.04%	181
2014 Q3	$25K	Buy	+54	New	+$14.5K	0.02%	243

Other funds holding TTPH

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Formidable Asset Management's TTPH Position: Q3 2015 in Review

Formidable Asset Management sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q3 2015, closing a stake of 791 shares — an estimated $751K sold.

Formidable Asset Management first reported a position in TTPH in Q3 2014 and held it in 4 quarters. The position peaked at $751K in Q2 2015. 105 funds tracked by Wall St. Rank hold TTPH as of Q3 2015.

Formidable Asset Management reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q3 2015 after selling out during the quarter.
Formidable Asset Management sold 791 Tetraphase Pharmaceuticals, Inc. shares in Q3 2015, an estimated $751K.
Formidable Asset Management first reported a position in Tetraphase Pharmaceuticals, Inc. in Q3 2014 and held it in 4 quarters.
Formidable Asset Management's Tetraphase Pharmaceuticals, Inc. position peaked at $751K in Q2 2015.
105 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q3 2015.

Based on Formidable Asset Management's 13F filing for Q3 2015, filed 12 Nov 2015.